Role of Dendritic Cell Activation in the Pathogenesis of Hepatic Fibrosis
$148,595K08FY2014DKNIH
New York University School Of Medicine, New York NY
Investigators
Linked publications & trials
Paper 28394331Paper 27559045Paper 26655905Paper 25950489Paper 24801349Paper 24216479Paper 23549168Paper 23536633Paper 23322710Paper 23023703Paper 22908323Paper 22705178Paper 22391448Paper 21801698Paper 21574173Paper 20639479Paper 20042467Paper 19855130
Abstract
Specific aims of this study are (i) To determine whether liver DC convert from inert inducers of tolerance to potent immune-stimulators and mediators of inflammation in liver fibrosis, (ii) To determine the contributory role of DC in the pathogenesis of fibrosis and their direct role in HSC activation, (iii) To determine whether blockade of the immunogenic function of liver DC can mitigate the fibrogenic response to liver injury. In vitro and in vivo experiments in Aims 2 and 3 were affected by our loss of cell cultures, mice, and our lab shutdown and then relocation. An extension will help us complete the Aims of the grant which has been very fruitful till this point.
View original record on NIH RePORTER →